Sight Sciences, Inc. (SGHT): Company Cash Volume

Official company branding of Sight Sciences, Inc (SGHT)

Changes in the cash balances of Sight Sciences, Inc. (SGHT) demonstrate financial resilience amid pressure from insurance payouts and competition in the glaucoma niche. The innovative OMNI system provides a competitive edge by enabling rapid fluid outflow recovery without implantation. Stringent patents and FDA requirements create a robust defensive barrier. The value of 0.08 determines the latest liquidity assessment metric for the company.

Company Cash Funds: Sight Sciences Inc (SGHT) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Sight Sciences Inc. (SGHT)

- stock quotes and analyst forecast:
Initial company analysis:Sight Sciences Inc SGHT
Brand item of Sight Sciences

It is critical for investors to determine whether the financial stability of Sight Sciences, Inc. (SGHT) results from operational efficiency or is a temporary effect of reserves. Amid the development of minimally invasive ophthalmology in the US, liquidity ensures the seamless operation of patent-protected production facilities. By analyzing the cash-on-hand metric, we assess the daily cash balance and the yield from its placement. The balance between excess capital and investments in the core business determines the long-term strength of the issuer.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Company Cash Reserve Neuronetics, Inc. STIM|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)